Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)
Table 8
Subgroup analyses according to fasting insulin level—mean ± SE ().
NGT ()
HINS ()
IGT ()
T2DM ()
FINS < 15 ()
FINS ≥ 15 ()
FINS < 15 ()
FINS ≥ 15 ()
FINS < 15 ()
FINS ≥ 15 ()
Weight
62.20 ± 6.75
75.50 ± 10.66
72.13 ± 10.45
84.67 ± 14.79
BMI
22.41 ± 1.54
26.38 ± 2.80
25.76 ± 2.76
26.09 ± 3.43
Waistline
76.75 ± 7.72
87.21 ± 9.90
87.41 ± 8.78
88.62 ± 10.90
WHR
0.90 ± 0.11
0.93 ± 0.10
0.92 ± 0.06
0.95 ± 0.06
TG
1.24 ± 0.73
2.80 ± 1.52
1.49 ± 0.69
1.78 ± 0.86
HDL
1.62 ± 0.35
1.35 ± 0.35
1.36 ± 0.39
1.07 ± 0.22
FINS
5.29 ± 4.61
8.78 ± 4.20
7.82 ± 3.76
6.80 ± 3.56
value
6.57 ± 1.40
7.53 ± 1.44
6.43 ± 1.78
Matsuda index
13.16 ± 7.24
5.36 ± 2.05
3.64 ± 0.95
8.28 ± 3.34
3.00 ± 0.94
6.87 ± 3.35
1.69 ± 0.49
Notes: comparison among HINS, IGT, and T2DM groups, , compared with nonfasting hyperinsulinemia subgroup; in fasting hyperinsulinemia subgroup, comparison among different glucose tolerance groups, compared with HINS and , compared with IGT.
